299 related articles for article (PubMed ID: 37111802)
1. Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers.
Teixeira PV; Fernandes E; Soares TB; Adega F; Lopes CM; Lúcio M
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111802
[TBL] [Abstract][Full Text] [Related]
2. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
Chen D; Liu X; Lu X; Tian J
Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
[TBL] [Abstract][Full Text] [Related]
4. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant.
Liang Y; Liu ZY; Wang PY; Li YJ; Wang RR; Xie SY
J Control Release; 2021 Aug; 336():396-409. PubMed ID: 34175367
[TBL] [Abstract][Full Text] [Related]
5. Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents.
Liu W; Ma X; Kheyr SM; Dong A; Zhang J
Materials (Basel); 2022 Oct; 15(20):. PubMed ID: 36295281
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.
Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH
Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
Zhao J; Feng SS
Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent-loaded nanoparticles.
Siddiquee T; Bhaskaran NA; Nathani K; Sawarkar SP
Phytother Res; 2024 May; ():. PubMed ID: 38806412
[TBL] [Abstract][Full Text] [Related]
11. Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer.
Chavda VP; Nalla LV; Balar P; Bezbaruah R; Apostolopoulos V; Singla RK; Khadela A; Vora L; Uversky VN
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831369
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy.
Kumar K; Rani V; Mishra M; Chawla R
Curr Res Pharmacol Drug Discov; 2022; 3():100103. PubMed ID: 35586474
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy.
Al Bostami RD; Abuwatfa WH; Husseini GA
Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957103
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
[No Abstract] [Full Text] [Related]
17. Membrane-core nanoparticles for cancer nanomedicine.
Guo J; Huang L
Adv Drug Deliv Rev; 2020; 156():23-39. PubMed ID: 32450105
[TBL] [Abstract][Full Text] [Related]
18. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
Olov N; Bagheri-Khoulenjani S; Mirzadeh H
J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
Babu A; Munshi A; Ramesh R
Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
